---
figid: PMC4741618__oncotarget-06-31461-g008
figtitle: Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug
  resistance in cancer cells
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
- Armoracia rusticana
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4741618
filename: oncotarget-06-31461-g008.jpg
figlink: /pmc/articles/PMC4741618/figure/F8/
number: F8
caption: Self-assembling nanoparticles encapsulating zoledronic acid (NZ) inhibit
  the farnesyl pyrophosphate synthase (FPPS) step in the mevalonate (Mev) pathway.
  So doing, NZ reduces the Ras/ERK1/2/HIF-1α-mediated transcription of P-glycoprotein
  (Pgp), the transcription of glycolytic genes, the synthesis of ubiquinone (UQ) and
  the mitochondrial electron flux, thus limiting the supply of ATP for Pgp, multidrug
  resistance related proteins (MRPs) and breast cancer resistance protein (BCRP).
  Overall these events increase the intracellular retention and toxicity of chemotherapeutic
  drugs (d).
papertitle: Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug
  resistance in cancer cells.
reftext: Joanna Kopecka, et al. Oncotarget. 2015 Oct 13;6(31):31461-31478.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9644898
figid_alias: PMC4741618__F8
figtype: Figure
redirect_from: /figures/PMC4741618__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4741618__oncotarget-06-31461-g008.html
  '@type': Dataset
  description: Self-assembling nanoparticles encapsulating zoledronic acid (NZ) inhibit
    the farnesyl pyrophosphate synthase (FPPS) step in the mevalonate (Mev) pathway.
    So doing, NZ reduces the Ras/ERK1/2/HIF-1α-mediated transcription of P-glycoprotein
    (Pgp), the transcription of glycolytic genes, the synthesis of ubiquinone (UQ)
    and the mitochondrial electron flux, thus limiting the supply of ATP for Pgp,
    multidrug resistance related proteins (MRPs) and breast cancer resistance protein
    (BCRP). Overall these events increase the intracellular retention and toxicity
    of chemotherapeutic drugs (d).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Pgp
  - Abcb1a
  - Pgpep1
  - Abcg2
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - FDPS
  - PGP
  - ABCB1
  - PGPEP1
  - ATP8A2
  - MRPS7
  - MRPS2
  - MRPS5
  - MRPS6
  - MRPS9
  - MRPS10
  - MRPS11
  - MRPS12
  - MRPS14
  - MRPS15
  - MRPS16
  - MRPS17
  - MRPS18A
  - MRPS18B
  - MRPS18C
  - MRPS21
  - MRPS22
  - MRPS23
  - MRPS24
  - MRPS25
  - MRPS26
  - MRPS27
  - MRPS28
  - DAP3
  - MRPS30
  - MRPS31
  - MRPS33
  - MRPS34
  - MRPS35
  - MRPS36
  - ABCG2
  - Ras64B
  - Ras85D
  - Fpps
  - l(1)16Fq
  - Mdr65
  - ATPsynbeta
  - Atpalpha
---
